Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Gilks, E. Allott, G. Donohoe, E. Cummings, M. Gill, A. Corvin, D. Morris (2010)
Replicated genetic evidence supports a role for HOMER2 in schizophreniaNeuroscience Letters, 468
Peter Marschang, Peter Marschang, Jochen Brich, Jochen Brich, E. Weeber, J. Sweatt, J. Shelton, J. Richardson, R. Hammer, J. Herz (2004)
Normal Development and Fertility of Knockout Mice Lacking the Tumor Suppressor Gene LRP1b Suggest Functional Compensation by LRP1Molecular and Cellular Biology, 24
R. Devon, S. Anderson, P. Teague, W. Muir, V. Murray, A. Pelosi, D. Blackwood, D. Porteous (2001)
The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophreniaMolecular Psychiatry, 6
N. Kolomeets, D. Orlovskaya, V. Rachmanova, N. Uranova (2005)
Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: A postmortem morphometric studySynapse, 57
D. Clair, D. Blackwood, W. Muir, M. Walker, A. Carothers, G. Spowart, C. Gosden, H. Evans (1990)
Association within a family of a balanced autosomal translocation with major mental illnessThe Lancet, 336
T. Kiss, W. Hoffmann, Liam Scott, T. Kawabe, A. Milici, E. Nilsen, M. Hajós (2011)
Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term PlasticityFrontiers in Psychiatry, 2
H. Stefánsson, R. Ophoff, S. Steinberg, O. Andreassen, S. Cichon, D. Rujescu, T. Werge, O. Pietiläinen, O. Mors, P. Mortensen, E. Sigurdsson, Ó. Gústafsson, M. Nyegaard, A. Tuulio-Henriksson, A. Ingason, T. Hansen, J. Suvisaari, J. Lonnqvist, T. Paunio, A. Børglum, A. Hartmann, A. Fink-Jensen, M. Nordentoft, D. Hougaard, B. No̸rgaard-Pedersen, Y. Böttcher, J. Olesen, R. Breuer, H. Möller, I. Giegling, H. Rasmussen, S. Timm, M. Mattheisen, I. Bitter, J. Réthelyi, B. Magnúsdóttir, T. Sigmundsson, Pall Olason, G. Másson, J. Gulcher, M. Haraldsson, R. Fossdal, T. Thorgeirsson, U. Thorsteinsdóttir, M. Ruggeri, S. Tosato, B. Franke, E. Strengman, L. Kiemeney, I. Melle, S. Djurovic, L. Abramova, V. Kaleda, J. Sanjuán, R. Frutos, E. Bramon, E. Vassos, Gillian Fraser, U. Ettinger, M. Picchioni, N. Walker, T. Toulopoulou, A. Need, D. Ge, J. Yoon, K. Shianna, N. Freimer, R. Cantor, R. Murray, A. Kong, V. Golimbet, Á. Carracedo, C. Arango, J. Costas, E. Jönsson, L. Terenius, I. Agartz, H. Pétursson, M. Nöthen, M. Rietschel, P. Matthews, P. Muglia, L. Peltonen, D. Clair, D. Goldstein, K. Stefánsson, D. Collier (2009)
Common variants conferring risk of schizophreniaNature, 460
M. Pietraszek, J. Nagel, A. Gravius, D. Schäfer, W. Danysz (2007)
The role of group I metabotropic glutamate receptors in schizophreniaAmino Acids, 32
J. Elia, J. Elia, J. Glessner, Kai Wang, N. Takahashi, Corina Shtir, D. Hadley, P. Sleiman, Haitao Zhang, Cecilia Kim, Reid Robison, G. Lyon, J. Flory, J. Bradfield, M. Imieliński, C. Hou, E. Frackelton, R. Chiavacci, T. Sakurai, C. Rabin, F. Middleton, Kelly Thomas, M. Garris, F. Mentch, C. Freitag, H. Steinhausen, H. Steinhausen, H. Steinhausen, A. Todorov, A. Reif, A. Rothenberger, B. Franke, E. Mick, H. Roeyers, J. Buitelaar, K. Lesch, T. Banaschewski, R. Ebstein, F. Mulas, R. Oades, J. Sergeant, E. Sonuga-Barke, E. Sonuga-Barke, E. Sonuga-Barke, T. Renner, M. Romanos, J. Romanos, A. Warnke, S. Walitza, S. Walitza, Jobst Meyer, H. Pálmason, C. Seitz, S. Loo, S. Smalley, J. Biederman, L. Kent, P. Asherson, R. Anney, J. Gaynor, P. Shaw, M. Devoto, P. White, S. Grant, S. Grant, J. Buxbaum, J. Rapoport, N. Williams, S. Nelson, S. Faraone, H. Hakonarson (2011)
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorderNature Genetics, 44
J. Haas, Arno Beer, P. Widschwendter, J. Oberdanner, Karin Salzmann, B. Sarg, Herbert Lindner, Joachim Herz, Josef Patsch, Peter Marschang (2011)
LRP1b shows restricted expression in human tissues and binds to several extracellular ligands, including fibrinogen and apoE – carrying lipoproteinsAtherosclerosis, 216
William Buchser, T. Slepak, Omar Gutierrez-Arenas, J. Bixby, V. Lemmon (2010)
Kinase/phosphatase overexpression reveals pathways regulating hippocampal neuron morphologyMolecular Systems Biology, 6
B. Zundert, Akira Yoshii, M. Constantine‐Paton (2004)
Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposalTrends in Neurosciences, 27
MT Tsuang (1993)
Genotypes, phenotypes, and the brain: a search for connections in schizophrenia., 163
I. Spellmann, D. Rujescu, R. Musil, A. Mayr, I. Giegling, J. Genius, P. Zill, S. Dehning, M. Opgen-Rhein, A. Cerovecki, A. Hartmann, M. Schäfer, B. Bondy, N. Müller, H. Möller, M. Riedel (2011)
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.Journal of psychiatric research, 45 2
Bin Xu, J. Roos, S. Levy, E. Rensburg, J. Gogos, M. Karayiorgou (2008)
Strong association of de novo copy number mutations with sporadic schizophreniaNature Genetics, 40
Jun Kitano, Y. Yamazaki, K. Kimura, Tomoko Masukado, Y. Nakajima, S. Nakanishi (2003)
Tamalin Is a Scaffold Protein That Interacts with Multiple Neuronal Proteins in Distinct Modes of Protein-Protein Association*The Journal of Biological Chemistry, 278
S. Girard, J. Gauthier, A. Noreau, L. Xiong, Sirui Zhou, L. Jouan, Alexandre Dionne‐Laporte, D. Spiegelman, Édouard Henrion, Ousmane Diallo, P. Thibodeau, I. Bachand, Jessie Bao, A. Tong, Chi-Ho Lin, B. Millet, N. Jaafari, R. Joober, P. Dion, S. Lok, M. Krebs, G. Rouleau (2011)
Increased exonic de novo mutation rate in individuals with schizophreniaNature Genetics, 43
JT Coyle, D Balu, M Benneyworth, A Basu, A Roseman (2010)
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia., 12
Bin Xu, J. Roos, P. Dexheimer, B. Boone, Brooks Plummer, S. Levy, J. Gogos, M. Karayiorgou (2011)
Exome sequencing supports a de novo mutational paradigm for schizophreniaNature genetics, 43
Eugene Davydov, D. Goode, M. Sirota, G. Cooper, A. Sidow, S. Batzoglou (2010)
Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++PLoS Computational Biology, 6
G. Cooper, Bradley Coe, S. Girirajan, J. Rosenfeld, Tiffany Vu, Carl Baker, C. Williams, H. Stalker, R. Hamid, V. Hannig, H. Abdel-Hamid, P. Bader, Elizabeth McCracken, D. Niyazov, K. Leppig, Heidi Thiese, M. Hummel, Nora Alexander, J. Gorski, J. Kussmann, V. Shashi, Krys Johnson, C. Rehder, B. Ballif, L. Shaffer, E. Eichler (2011)
A Copy Number Variation Morbidity Map of Developmental DelayNature genetics, 43
G. Bu, J. Cam, C. Zerbinatti (2006)
LRP in Amyloid‐β Production and MetabolismAnnals of the New York Academy of Sciences, 1086
M. Swami (2011)
New from NPG: Genome-wide association study identifies five new schizophrenia lociNature Medicine, 17
G. Kirov, A. Pocklington, P. Holmans, D. Ivanov, M. Ikeda, D. Ruderfer, D. Ruderfer, J. Moran, K. Chambert, D. Toncheva, L. Georgieva, D. Grozeva, M. Fjodorova, Rebecca Wollerton, E. Rees, I. Nikolov, L. Lagemaat, À. Bayés, Estefania Fernandez, Pall Olason, Y. Bottcher, N. Komiyama, M. Collins, J. Choudhary, K. Stefánsson, H. Stefánsson, S. Grant, S. Purcell, S. Purcell, P. Sklar, P. Sklar, M. O’Donovan, M. Owen (2011)
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophreniaMolecular Psychiatry, 17
C. Ku, Constantin Polychronakos, E. Tan, N. Naidoo, Yudi Pawitan, Dimitrios Roukos, Matthew Mort, David Cooper (2013)
A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental diseaseMolecular Psychiatry, 18
Stuart Brody, S. Dulawa, S. Dulawa, F. Conquet, Mark Geyer (2004)
Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptorsMolecular Psychiatry, 9
P. Gejman, A. Sanders, K. Kendler (2011)
Genetics of schizophrenia: new findings and challenges.Annual review of genomics and human genetics, 12
Jennifer Stone, M. O’Donovan, H. Gurling, G. Kirov, Douglas Blackwood, A. Corvin, N. Craddock, M. Gill, C. Hultman, Paul Lichtenstein, A. McQuillin, C. Pato, D. Ruderfer, M. Owen, D. Clair, Patrick Sullivan, P. Sklar, S. Purcell, Joshua Korn, Stuart Macgregor, Derek Morris, C. O’Dushlaine, Mark Daly, P. Visscher, P. Holmans, E. Scolnick, Nigel Williams, Lucy Georgieva, I. Nikolov, Nadine Norton, H. Williams, D. Toncheva, V. Milanova, E. Thelander, Patrick Sullivan, E. Kenny, J. Waddington, K. Choudhury, S. Datta, J. Pimm, S. Thirumalai, V. Puri, R. Krasucki, J. Lawrence, D. Quested, N. Bass, David Curtis, C. Crombie, Gillian Fraser, Soh Kwan, N. Walker, W. Muir, K. McGhee, Ben Pickard, P. Malloy, A. Maclean, Margaret Beck, M. Pato, H. Medeiros, Frank Middleton, C. Carvalho, C. Morley, A. Fanous, David Conti, J. Knowles, C. Ferreira, A. Macedo, M. Azevedo, S. McCarroll, K. Chambert, Casey Gates, S. Gabriel, Scott Mahon, Kristen Ardlie (2008)
Rare chromosomal deletions and duplications increase risk of schizophreniaNature, 455
M. Tsuang (1993)
Genotypes, Phenotypes, and the BrainBritish Journal of Psychiatry, 163
M. Kutuzov, O. Solov’eva, A. Andreeva, N. Bennett (2002)
Protein Ser/Thr phosphatases PPEF interact with calmodulin.Biochemical and biophysical research communications, 293 3
K. Kanuma, T. Aoki, Youichi Shimazaki (2010)
Recent patents on positive allosteric modulators of the metabotropic glutamate 5 receptor as a potential treatment for schizophrenia.Recent patents on CNS drug discovery, 5 1
M. Ayalew, H. Le-Niculescu, D. Levey, N. Jain, B. Changala, S. Patel, E. Winiger, A. Breier, A. Shekhar, R. Amdur, Daniel Koller, J. Nurnberger, A. Corvin, M. Geyer, M. Tsuang, D. Salomon, N. Schork, A. Fanous, M. O’Donovan, A. Niculescu (2012)
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk predictionMolecular Psychiatry, 17
G. Bu, J. Cam, C. Zerbinatti (2006)
LRP in amyloid-beta production and metabolism.Annals of the New York Academy of Sciences, 1086
S Ripke, AR Sanders, KS Kendler (2011)
Genome-wide association study identifies five new schizophrenia loci., 43
J. Coyle, D. Balu, M. Benneyworth, A. Basu, Alex Roseman (2010)
PAGES_DCNS 46_5.qxd:DCNS#45
S. Girirajan, Z. Brkanac, Bradley Coe, Carl Baker, Laura Vives, Tiffany Vu, Neil Shafer, R. Bernier, G. Ferrero, M. Silengo, S. Warren, C. Moreno, M. Fichera, C. Romano, W. Raskind, E. Eichler (2011)
Relative Burden of Large CNVs on a Range of Neurodevelopmental PhenotypesPLoS Genetics, 7
H. Stefánsson, D. Rujescu, S. Cichon, O. Pietiläinen, A. Ingason, S. Steinberg, R. Fossdal, E. Sigurdsson, T. Sigmundsson, J. Buizer-Voskamp, T. Hansen, K. Jakobsen, P. Muglia, C. Francks, P. Matthews, Arnaldur Gylfason, Bjarni Halldórsson, D. Gudbjartsson, T. Thorgeirsson, A. Sigurdsson, A. Jonasdottir, Á. Jónasdóttir, A. Bjornsson, Sigurborg Mattiasdottir, T. Blondal, M. Haraldsson, B. Magnúsdóttir, I. Giegling, H. Möller, A. Hartmann, K. Shianna, D. Ge, A. Need, C. Crombie, Gillian Fraser, N. Walker, J. Lonnqvist, J. Suvisaari, A. Tuulio-Henriksson, T. Paunio, T. Toulopoulou, E. Bramon, M. Forti, R. Murray, M. Ruggeri, E. Vassos, S. Tosato, M. Walshe, Tao Li, Catalina Vasilescu, Thomas Mühleisen, August Wang, H. Ullum, S. Djurovic, I. Melle, J. Olesen, L. Kiemeney, B. Franke, C. Sabatti, N. Freimer, J. Gulcher, U. Thorsteinsdóttir, A. Kong, O. Andreassen, R. Ophoff, A. Georgi, M. Rietschel, T. Werge, H. Pétursson, D. Goldstein, M. Nöthen, L. Peltonen, D. Collier, D. Clair, K. Stefánsson (2008)
Large recurrent microdeletions associated with schizophreniaNature, 455
Chun-Xiang Liu, Yonghe Li, Lynn Obermoeller-McCormick, A. Schwartz, G. Bu (2001)
The Putative Tumor Suppressor LRP1B, a Novel Member of the Low Density Lipoprotein (LDL) Receptor Family, Exhibits Both Overlapping and Distinct Properties with the LDL Receptor-related Protein*The Journal of Biological Chemistry, 276
A. Bassett, G. Costain, W. Fung, Kathryn Russell, Laura Pierce, Ronak Kapadia, R. Carter, E. Chow, P. Forsythe (2010)
Clinically detectable copy number variations in a Canadian catchment population of schizophrenia.Journal of psychiatric research, 44 15
S. Girirajan, E. Eichler (2010)
Phenotypic variability and genetic susceptibility to genomic disorders.Human molecular genetics, 19 R2
Wen-Yun Yang, J. Novembre, E. Eskin, E. Halperin (2012)
A model-based approach for analysis of spatial structure in genetic dataNature Genetics, 44
J. Nurnberger, M. Blehar, C. Kaufmann, Carolyn York-Cooler, S. Simpson, J. Harkavy-Friedman, J. Severe, D. Malaspina, T. Reich (1994)
Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.Archives of general psychiatry, 51 11
Tohru Ohnuma, S. Augood, H. Arai, Peter McKenna, Piers Emson (1998)
Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.Brain research. Molecular brain research, 56 1-2
V. Mittal, E. Walker (2011)
Diagnostic and Statistical Manual of Mental DisordersPsychiatry Research, 189
A. Bassett, S. Scherer, L. Brzustowicz (2010)
Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease.The American journal of psychiatry, 167 8
M. Ng, D. Levinson, S. Faraone, B. Suarez, L. DeLisi, L. DeLisi, T. Arinami, B. Riley, T. Paunio, T. Paunio, A. Pulver, Irmansyah, P. Holmans, M. Escamilla, D. Wildenauer, N. Williams, Claudine Laurent, B. Mowry, L. Brzustowicz, M. Maziade, P. Sklar, D. Garver, G. Abecasis, B. Lerer, M. Fallin, H. Gurling, P. Gejman, E. Lindholm, H. Moises, W. Byerley, E. Wijsman, P. Forabosco, M. Tsuang, M. Tsuang, H. Hwu, Y. Okazaki, K. Kendler, B. Wormley, A. Fanous, D. Walsh, F. O’Neill, L. Peltonen, G. Nestadt, V. Lasseter, K. Liang, G. Papadimitriou, D. Dikeos, S. Schwab, M. Owen, M. O’Donovan, N. Norton, E. Hare, H. Raventós, H. Nicolini, M. Albus, Wolfgang Maier, V. Nimgaonkar, L. Terenius, Jacques Mallet, M. Jay, S. Godard, D. Nertney, Madeline Alexander, R. Crowe, J. Silverman, A. Bassett, M. Roy, C. Mérette, C. Pato, M. Pato, J. Roos, Y. Kohn, D. Amann-Zalcenstein, G. Kalsi, A. McQuillin, D. Curtis, Jon Brynjolfson, T. Sigmundsson, H. Pétursson, A. Sanders, J. Duan, E. Jazin, M. Myles‐Worsley, M. Karayiorgou, C. Lewis (2009)
Meta-analysis of 32 genome-wide linkage studies of schizophreniaMolecular Psychiatry, 14
T. Walsh, J. McClellan, S. McCarthy, A. Addington, S. Pierce, G. Cooper, A. Nord, M. Kusenda, D. Malhotra, A. Bhandari, S. Stray, C. Rippey, P. Roccanova, Vladimir Makarov, B. Lakshmi, R. Findling, L. Sikich, T. Stromberg, B. Merriman, N. Gogtay, P. Butler, K. Eckstrand, L. Noory, P. Gochman, R. Long, Zugen Chen, S. Davis, Carl Baker, E. Eichler, P. Meltzer, S. Nelson, A. Singleton, Ming Lee, J. Rapoport, M. King, J. Sebat (2008)
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in SchizophreniaScience, 320
(1992)
Family Interview for Genetic Studies (FIGS): A Manual for FIGS. Bethesda, MD: NIMH Clinical Neurogenetics Branch
ME Maxwell
Family Interview for Genetic Studies (FIGS): A Manual for FIGS.
M. DeMichele-Sweet, R. Sweet (2010)
Genetics of psychosis in Alzheimer's disease: a review.Journal of Alzheimer's disease : JAD, 19 3
G. Lavezzari, Jennifer McCallum, Colleen Dewey, K. Roche (2004)
Subunit-Specific Regulation of NMDA Receptor EndocytosisThe Journal of Neuroscience, 24
J. Millar, Julie Wilson-Annan, S. Anderson, S. Christie, Martin Taylor, C. Semple, R. Devon, D. Clair, W. Muir, Douglas Blackwood, D. Porteous (2000)
Disruption of two novel genes by a translocation co-segregating with schizophrenia.Human molecular genetics, 9 9
C. Cloninger, C. Kaufmann, S. Faraone, D. Malaspina, D. Svrakic, J. Harkavy-Friedman, B. Suarez, T. Matise, T. Matise, D. Shore, Hang Lee, C. Hampe, D. Wynne, Caroline Drain, P. Markel, Christopher Zambuto, Karin Schmitt, M. Tsuang (1998)
Genome-wide search for schizophrenia susceptibility loci: the NIMH Genetics Initiative and Millennium Consortium.American journal of medical genetics, 81 4
Janet Williams (2013)
Diagnostic and Statistical Manual of Mental Disorders
ORIGINAL ARTICLE Support for the N-Methyl-D-Aspartate Receptor Hypofunction Hypothesis of Schizophrenia From Exome Sequencing in Multiplex Families Andrew E. Timms, PhD; Michael O. Dorschner, PhD; Jeremy Wechsler, MS; Kyu Yeong Choi, PhD; Robert Kirkwood, BA; Santhosh Girirajan, MBBS, PhD; Carl Baker, BS; Evan E. Eichler, PhD; Olena Korvatska, PhD; Katherine W. Roche, PhD; Marshall S. Horwitz, MD, PhD; Debby W. Tsuang, MD, MSc Importance: Schizophrenia is a complex genetic disor- Main Outcome Measures: Rare inherited disease- der demonstrating considerable heritability. Genetic stud- related genetic mutations. ies have implicated many different genes and pathways, but much of the genetic liability remains unaccounted for. In- Results: No segregating rare copy number variants were vestigation of genetic forms of schizophrenia will lead to a detected by array comparative genomic hybridization. better understanding of the underlying molecular path- However, in all 5 families, exome sequencing detected ways, which will then enable targeted approaches for dis- rare protein-altering variants in 1 of 3 genes associated ease prevention and treatment. with the N-methyl-D-aspartate (NMDA) receptor. One pedigree shared a missense and frameshift substitution Objective: To identify new genetic factors strongly pre- of GRM5, encoding the metabotropic glutamate recep- disposing to schizophrenia in families with multiple
JAMA Psychiatry – American Medical Association
Published: Jun 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.